Ye Wang

A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer

Xinyu Wan, X. Zha, Wenjie Shi, 2022, Frontiers in Endocrinology.

Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic non-small cell lung cancer in China

Yujie Zhou, Hongya Wang, Y. Long, 2022, Frontiers in Oncology.

Volume change rate before and after neoadjuvant systemic therapy of breast cancer is an efficacious evaluation index to predict pathological complete response

Xinyu Wan, Wenjie Shi, Lu Xu, 2023, Frontiers in Oncology.

Comparison of clinicopathological characteristics and response to neoadjuvant systemic therapy in patients with HER2-low-positive and HER2-zero breast cancer

Xinyu Wan, Wenjie Shi, Lu Xu, 2023, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancer.

Ye Wang, Xinyu Wan, Lexin Wang, 2023, Nanomedicine : nanotechnology, biology, and medicine.

Prognostic analysis of three forms of Ki‐67 in patients with breast cancer with non‐pathological complete response before and after neoadjuvant systemic treatment

Xinyu Wan, Wenjie Shi, Jue Wang, 2023, Cancer medicine.

A prospective, randomized clinical trial of emergency treatment of chemotherapy‐induced neutropenia and febrile neutropenia by pegylated recombinant human granulocyte colony‐stimulating factor (PEG‐rhG‐CSF)

X. Zha, Jue Wang, Lu Xu, 2022, British journal of clinical pharmacology.

Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis

Xinyu Wan, X. Zha, Wenjie Shi, 2022, Breast.

Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer.

X. Zha, Cui-ying Li, Jue Wang, 2022, Nanomedicine.

GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors.

Beicheng Sun, Qi Liu, Yanchao Xu, 2022, Cancer research.

Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer.

Xinyu Wan, Lu Xu, Jue Wang, 2023, Nanomedicine : nanotechnology, biology, and medicine.